Does ELACESTRANT Cause Hepatic function abnormal? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic function abnormal have been filed in association with ELACESTRANT (ORSERDU). This represents 0.1% of all adverse event reports for ELACESTRANT.
9
Reports of Hepatic function abnormal with ELACESTRANT
0.1%
of all ELACESTRANT reports
3
Deaths
3
Hospitalizations
How Dangerous Is Hepatic function abnormal From ELACESTRANT?
Of the 9 reports, 3 (33.3%) resulted in death, 3 (33.3%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELACESTRANT. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ELACESTRANT Cause?
Nausea (1,454)
Fatigue (1,081)
Disease progression (777)
Vomiting (662)
Diarrhoea (540)
Death (499)
Drug ineffective (478)
Constipation (389)
Product dose omission issue (364)
Decreased appetite (363)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ELACESTRANT Alternatives Have Lower Hepatic function abnormal Risk?
ELACESTRANT vs ELAFIBRANOR
ELACESTRANT vs ELAGOLIX
ELACESTRANT vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
ELACESTRANT vs ELAPEGADEMASE-LVLR
ELACESTRANT vs ELASOMERAN